Study No. | Compound Dosed | Dosing Route | Dose | Biological Samples Analyzed |
---|---|---|---|---|
mg/kg | ||||
1a | PNU96391 | p.o. | 10 | Blood plasma (jugular vein) and urine |
[13C,2H3]PNU96391 | p.o. | 10 | ||
2b | PNU96391 | i.v. | 5 | Blood plasma (portal and jugular veins) and urine |
[13C,2H3]PNU96391 | p.o. | 10 | ||
3c | M1 | i.v. | 5 | Blood plasma (jugular vein) and urine |
| [13C,2H3]PNU96391 | p.o. | 10 |
|
↵ a Each animal (n = 2) was coadministered PNU96391 (10 mg/kg p.o.) with [13C,2H3]PNU96391 (10 mg/kg p.o.).
↵ b Each animal (n = 4) was coadministered PNU96391 (5 mg/kg i.v.) with [13C,2H3]PNU96391 (10 mg/kg p.o.).
↵ c Each animal (n = 4) was coadministered M1 (5 mg/kg i.v.) with [13C,2H3]PNU96391 (10 mg/kg p.o.).